SlideShare a Scribd company logo
1 of 74
College of Computing and Informatics
Department of Statistics
Biostatistics and Epidemiology
Chapter 1: Principles and Methods of Epidemiology
By: Dugo G. (MSc.)
Email: dugojgadisa@gmail.com or
Dugo.Gadisa@haramaya.edu.et
1
Introduction to Epidemiology and Biostatistics
What is the difference between the two?
ο‚΄Biostatistics is the application of statistical methods
in biology, medicine, public health, and other fields
of study.
ο‚΄Epidemiology is the study of patterns of health and
illness and associated factors at the population level
(disease distribution, prevalence, mechanisms of
prevention, etc.)
2
Introduction to Epidemiology
Definitions of Epidemiology
ο‚΄It is a study of the distribution of a disease or a
physiological condition in human populations and the
factors that influence this distribution.
ο‚΄It is a study of the distribution and determinants of health-
related states and events in populations and the application
of this study to control health problems.
3
What is Epidemiology?
ο‚΄In general, Epidemiology can be
defined as the study of determinants,
distribution, and frequency of
disease.
4
Uses of Epidemiology
a. Community diagnosis; i.e., what are the major health problems
occurring in a community
b. Establishing the history of a disease in a population; e.g.,
identifying the periodicity of an infectious disease
c. Describing the natural history of disease in the individual; e.g.,
natural history of Cancer in the individual (from its pathological
onset (inception) to resolution (recovery or death), clinical stages)
5
Uses of Epidemiology
d. Describing the clinical picture of the disease; i.e., who gets the
disease, who dies from the disease, and what the outcome of the
disease is
e. Estimating risk; e.g., what factors increase the risk of heart
disease, automobile accidents, and violence
f. Identifying syndromes and precursors; e.g., the relationship of
high blood pressure to stroke, kidney disease, and heart disease
ο‚΄Syndromes: a group of signs and symptoms that consistently occur
together and characterize a particular abnormality or condition.
ο‚΄Precursors: a substance, cell, or cellular component from which
another substance, cell, or cellular component is formed
6
Uses of Epidemiology
g. Evaluating prevention/intervention programs; e.g., vaccine
and clinical trials
h. Investigating epidemics/diseases of unknown etiology.
ο‚΄Etiology encompasses understanding why a particular
condition or disease occurs.
7
Some Epidemiologic Concepts
Catchment area:
ο‚΄The geographical area from which the people attending a
particular health facility come.
Catchment population :
ο‚΄People attending particular health facilities
ο‚΄Population at risk: is vital to know all people at risk of
developing a disease or having a health problem, as well
as those who are currently suffering from it.
8
Some Epidemiologic Concepts
ο‚΄Incidence: the number of new cases, or events
occurring over a defined period of time, commonly one
year.
ο‚΄Prevalence: the total number of existing cases, episodes or
events occurring at one point in time, commonly on a
particular day.
9
Some Epidemiologic Concepts
10
Some Epidemiologic Concepts
ο‚΄Case: A person who is identified as having a particular characteristic
such as a disease, behavior, or condition. Cases may be divided into
possible, probable, and definite, depending on how well specific
criteria are satisfied
ο‚΄Controls: refer to a specific group of individuals who serve as a
comparison for the group of people with a particular disease (known
as cases).
11
Some Epidemiologic Concepts
ο‚΄Epidemic: the occurrence in a community or region of cases of an
illness or other similar event clearly in excess of what is normally
expected. The characteristics of the illness, the area and the season
all have to be taken into account.
ο‚΄Epidemic incidence curve: a graph that plots cases of the disease
by the time of onset of the illness. An essential part of the analysis
is this graph can indicate the nature of the outbreak and the
probable source.
12
Mortality Rate
ο‚΄Crude Death Rate (CDR) =
π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘œπ‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™
πΈπ‘ π‘‘π‘–π‘šπ‘Žπ‘‘π‘’π‘‘ π‘šπ‘–π‘‘ π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
βˆ— 1000
ο‚΄The crude death rate was 5.995 per 1,000 in Ethiopia in 2023.
ο‚΄The crude death rate in Addis Ababa was approximately 6.29 per
1000 (data of 2020).
13
Age-specific Mortality Rate
ο‚΄Age-specific mortality rate =
π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑖𝑛 π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘Žπ‘”π‘’ π‘”π‘Ÿπ‘œπ‘’π‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
πΈπ‘ π‘‘π‘–π‘šπ‘Žπ‘‘π‘’π‘‘ π‘šπ‘–π‘‘βˆ’π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘œπ‘“ 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘Žπ‘”π‘’ π‘”π‘Ÿπ‘œπ‘’π‘
βˆ— 1000
ο‚΄One example of age specific mortality rate is Infant
Mortality Rate.
14
Sex-Specific Mortality Rate
ο‚΄Sex-specific mortality rate =
π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑖𝑛 π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑠𝑒π‘₯ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
πΈπ‘ π‘‘π‘–π‘šπ‘Žπ‘‘π‘’π‘‘ π‘šπ‘–π‘‘βˆ’π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘œπ‘“ π‘ π‘Žπ‘šπ‘’ 𝑠𝑒π‘₯
βˆ— 1000
Example: The average total population of β€œTown A” in 2019 was
6000 (3500 female & 2500 male). In the same year, 300 people died
(100 female and 200 male). Calculate the Crude death rate and
mortality rate for females.
15
Case Fatality Rate
ο‚΄Case Fatality Rate (CFR) =
π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘“π‘Ÿπ‘œπ‘š π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘‘π‘–π‘ π‘’π‘Žπ‘ π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
π‘π‘œ π‘œπ‘“ π‘π‘Žπ‘ π‘’π‘  π‘œπ‘“ π‘‘β„Žπ‘Žπ‘‘ π‘‘π‘–π‘ π‘’π‘Žπ‘ π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’
βˆ— 100
ο‚΄Example: In 1996, there were 1000 tuberculosis patients in
one region. Out of the 1000 patients, 100 died in the same
year. Calculate the case fatality rate of tuberculosis.
16
Neonatal Mortality Rate
ο‚΄Neonatal Mortality Rate =
π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘’π‘›π‘‘π‘’π‘Ÿ 28 π‘‘π‘Žπ‘¦π‘  π‘œπ‘“ π‘Žπ‘”π‘’ π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
π‘π‘œ π‘œπ‘“ 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’
βˆ— 1000
ο‚΄Example: In 2010, there were a total of 5000 live births in β€œZone B”.
Two hundred of them died before 28 days after birth. Calculate the
Neonatal Mortality Rate (NMR).
ο‚΄Answer: NMR =
200
500
βˆ— 1000 = 40 π‘π‘’π‘Ÿ 1000 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘ 
ο‚΄That means out of 1000 live births in 2010, 40 of them died before 28
days after birth.
17
Infant Mortality Rate (IMR)
ο‚΄Infant Mortality Rate (IMR) =
π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘œπ‘“ π‘’π‘›π‘‘π‘’π‘Ÿ 1 π‘¦π‘’π‘Žπ‘Ÿ π‘œπ‘“ π‘Žπ‘”π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
π‘π‘œ π‘œπ‘“ 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’
βˆ— 1000
18
Under-Five Mortality Rate
ο‚΄Under-five mortality rate =
π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘œπ‘“ 0βˆ’4 π‘¦π‘’π‘Žπ‘Ÿπ‘  π‘œπ‘“ π‘Žπ‘”π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
π΄π‘£π‘’π‘Ÿπ‘Žπ‘”π‘’ π‘šπ‘–π‘‘βˆ’π‘¦π‘’π‘Žπ‘Ÿ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘œπ‘“ π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘Žπ‘”π‘’ π‘Žπ‘‘ π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’
βˆ— 1000
ο‚΄ NB: The numerator says 0-4 years. 0-4 years in this formula means children from
birth to less than five years of age i.e. the upper age limit is not 4.
ο‚΄ Example: In 1996, the total number of children under 5 years of age was 10,000 in
β€œZone C”. In the same year, 200 children under five years of age died. Calculate the
under-five mortality rate (U5MR).
ο‚΄ U5MR =
200
10000
βˆ— 1000 = 20 π‘π‘’π‘Ÿ 1000 π‘’π‘›π‘‘π‘’π‘Ÿ 𝑓𝑖𝑣𝑒 π‘β„Žπ‘–π‘™π‘‘π‘Ÿπ‘’π‘›
19
Maternal Mortality Rate
ο‚΄ Maternal Mortality Rate =
π‘π‘œ π‘œπ‘“ π‘π‘Ÿπ‘’π‘”π‘›π‘Žπ‘›π‘π‘¦ π‘Žπ‘ π‘ π‘œπ‘π‘–π‘Žπ‘‘π‘’π‘‘ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘œπ‘“ π‘šπ‘œπ‘‘β„Žπ‘’π‘Ÿπ‘  𝑖𝑛 π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’
π‘π‘œ π‘œπ‘“ 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  𝑖𝑛 π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’
βˆ— 1000
ο‚΄ Maternal Mortality Rate reflects the standards of all aspects of maternal
care (antenatal, delivery, and postnatal).
ο‚΄ The Maternal Mortality Rate in Ethiopia is estimated to be between 267 to
412 per 100,000 live births in 2020.
ο‚΄ That means in 100,000 live births, on average around 340 mothers die
each year due to pregnancy-related causes.
20
Scope of Epidemiology
ο‚΄Its scope at the beginning was limited to understanding epidemics
ο‚΄Now it is the basis of advancing our understanding of all kinds of
diseases included:
ο‚΄Nutritional deficiencies
ο‚΄Infectious and non-infectious diseases
ο‚΄ Injuries and accidents
ο‚΄Mental disorders
ο‚΄Maternal and Child Health
ο‚΄Cancer
ο‚΄Occupational Health
ο‚΄Environmental Health
ο‚΄Health behaviors
21
Measuring Disease Frequency
It Has several Components
ο‚΄Classifying and categorizing disease
ο‚΄Defining the period of time of risk of disease
ο‚΄Deciding what constitutes a case of disease in a study
ο‚΄Obtaining permission to study people
ο‚΄Making measurements of disease frequency
ο‚΄Finding a source for ascertaining the cases
ο‚΄Relating cases to population and time at risk
ο‚΄Defining the population at risk of disease
22
The Basic Triad of Descriptive Epidemiology
ο‚΄The three essential characteristics of disease we look for in
descriptive epidemiology:
TIME
PLACE
PERSON
23
Time
There are three major kinds of changes in disease occurrence over
time.
1. SECULAR TRENDS (slowly change): This refers to gradual
changes over long period of time, such as years or decades.
E.g. AIDS, cancer.
2. PERIODIC OR CYCLIC CHANGES. This refers to recurrent
alterations in the frequency of diseases.
ο‚΄Cycles may be annual or have some other periodicity. E.g. measles,
malaria, meningitis.
3. SPORADIC: irregular and unpredictable intervals.
ο‚΄E.g. influenza, Allergies
24
Time (Cont’d…)
ο‚΄Secular trend can be due to one or more of the following factors.
1. Change in diagnostic technique
2. Change in accuracy of enumerating population at risk.
3. Change in age distribution of the people.
4. Change of survival from disease.
5. Change in actual incidence of the disease.
25
Time (Cont’d…)
ο‚΄Changing or Stable
ο‚΄Seasonal Variation
ο‚΄Clustered (Epidemic) or evenly distributed (Endemic)
ο‚΄Point source or Propagated
26
Place
ο‚΄The frequency of disease is different in different places.
ο‚΄Natural barriers: environmental or climatic conditions, such as
temperature, humidity, rainfall, altitude, mineral content of soil, or
water supply
ο‚΄Political boundaries: Intended for planning and allocation of
resources
ο‚΄Urban-rural differences in disease occurrence: in terms of
migration, style of living and differential environmental exposures
also helpful
27
Place (Cont’d…)
ο‚΄Geographically restricted or widespread (Pandemic)
ο‚΄Relation to food or water supply
ο‚΄Multiple clusters or one
28
Person
οƒ˜Age
οƒ˜Socio-economic status
οƒ˜Gender
οƒ˜Ethnicity
οƒ˜Behavior
29
Person (Who)
ο‚΄Young vs Old
ο‚΄Female vs male
ο‚΄Rich vs Poor
ο‚΄Illiterate Vs educate
Place (Where)
ο‚΄Lowland vs Highland
ο‚΄Urban vs Rural
Time (When)
ο‚΄Day/night variation
ο‚΄Seasonal variation
ο‚΄Long term
30
Disease Occurrence
Dynamics of Disease Transmission
ο‚΄Interaction of agents and environmental factors with human
hosts
ο‚΄Distribution of severity of diseases
ο‚΄Modes of disease transmission
ο‚΄Level of disease in community when transmission stops
31
The Basic Triad of Analytic Epidemiology
ο‚΄The three phenomena assessed in Analytic Epidemiology
are:
Host
Agent Environment
32
The Basic Triad of Analytic Epidemiology
ο‚΄Host: In epidemiology, the host is usually a human who gets sick
but can also be an animal that acts as a carrier of disease but may or
may not present illness.
ο‚΄Agent: Epidemiologic triangle agents include Bacteria, Viruses,
Fungi, Protozoa, et cetera.
ο‚΄Environment: The environment represents the favorable
conditions for an agent to cause a health event. Environmental
factors include physical features like geology or climate, biological
factors like the presence of disease-transmitting insects, and
socioeconomic factors like crowding, sanitation, and access to
health services.
33
Measuring Disease Frequency
ο‚΄Incidence
ο‚΄Prevalence
ο‚΄Defined time period
ο‚΄Population at risk
34
When Calculating DF(disease frequency)
ο‚΄The numerator (number of cases/episodes)
ο‚΄The denominator (total population at risk)
ο‚΄Factor (e.g. 100, 1000, 10000)
ο‚΄Time period (dates, weeks, months, or years)
ο‚΄We use the following to determine DF.
ο‚΄Use rates: incidence rates
ο‚΄Prevalence rates
35
Incidence and Prevalence rates
ο‚΄Decide what are you counting.
ο‚΄Episodes/cases, people, attendance or what?
ο‚΄What is the service count when filling monthly statistics eg.
diarrhea or malaria
ο‚΄people get repeated attacks in one month and attend your service
ο‚΄This is one person sick but has suffered several times separate
episodes in one year and attended your service several times
36
Incidence and Prevalence rates
ο‚΄Incidence: Count episodes/cases
ο‚΄Prevalence: chronic conditions/diseases which count the total
number of sick people.
ο‚΄To study the use of health services, informations on new attendance
and repeat attendance are required.
37
When Calculating:
ο‚΄Incidence rate:
𝐼𝑅 =
π‘π‘œ π‘œπ‘“ 𝑛𝑒𝑀 π‘π‘Žπ‘ π‘’π‘  π‘œπ‘“ π‘Ž π‘‘π‘–π‘ π‘’π‘Žπ‘ π‘’ π‘œπ‘£π‘’π‘Ÿ π‘Ž π‘π‘’π‘Ÿπ‘–π‘œπ‘‘ π‘œπ‘“ π‘‘π‘–π‘šπ‘’
π‘‡π‘œπ‘‘π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ 𝑔𝑖𝑣𝑒𝑛 π‘π‘’π‘Ÿπ‘–π‘œπ‘‘ π‘œπ‘“ π‘‘π‘–π‘šπ‘’
βˆ— 𝐾
ο‚΄Prevalence rate:
𝑃𝑅 =
𝐴𝑙𝑙 π‘π‘’π‘Ÿπ‘ π‘œπ‘›π‘  π‘€π‘–π‘‘β„Ž π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘π‘œπ‘›π‘‘π‘–π‘‘π‘–π‘œπ‘›π‘  π‘Žπ‘‘ π‘œπ‘›π‘’ π‘π‘œπ‘–π‘›π‘‘ 𝑖𝑛 π‘‘π‘–π‘šπ‘’
π‘‡π‘œπ‘‘π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘›
βˆ— 𝐾
38
Example 1: In September 1995 there were 200 new cases of
relapsing fever in β€œKebele X”. The average total population of
β€œKebele X” was 4000. Calculate the incidence rate of relapsing fever
in β€œKebele X” in September 1995. Answer: 50 new cases per 1000
Example 2: 5,600,000 people in South Africa were estimated to be
infected with HIV in 2009 with a total population of 53 million. What
is the prevalence of HIV in the South? Answer:
39
Comparing Incidence and Prevalence
Incidence
ο‚΄New cases or events over a
period of time
ο‚΄Useful to study factors
causing risks
Prevalence
ο‚΄All cases at a point/interval
of time
ο‚΄Useful for measuring the size
of the problem and planning
40
Relationship of Incidence to Prevalence
ο‚΄Prevalence depends on both on incidence rate and duration of
disease
ο‚΄Because prevalence is affected by factors such as migration and
duration, incidence is preferred for studying etiology.
ο‚΄Prevalence = Incidence X Duration
41
Relationship between Incidence, Prevalence and Disease
Duration
42
Incidence
Prevalence Death
Lost to follow up
Cure
Attack Rate
ο‚΄Example: Consider the outbreak of cholera in country Y in
March 2016. 490 population with cholera and the population at
risk were 18,600. What is the AR?
ο‚΄Answer: 𝐴𝑅 =
490
18,600
βˆ— 100% = 2.6%
43
Relative Risk (RR) or Risk Ratio
ο‚΄Defined as the ratio of the incidence of disease in the exposed
divided by the corresponding non-exposed group.
44
Exposure Disease Total
Yes No
Yes a b a+b
No c d c+d
Total a+c b+d N
Relative Risk (RR) or Risk Ratio
ο‚΄Where, 𝑝1 = π‘Ž/(π‘Ž + 𝑏) and 𝑝2 = 𝑐/(𝑐 + 𝑑)
ο‚΄A point estimate of the risk ratio is given by:
οƒ˜ 𝑅𝑅 =
𝑝1
𝑝2
45
Relative Risk (RR) or Risk Ratio
Example
46
1st give
Birth
Breast Cancer
Total
Yes No
β‰₯25 years 31 1597 1628
<25 years 65 4475 4540
96 6072 6168
Relative Risk (RR) or Risk Ratio
𝑝1 = π‘Ž/(π‘Ž + 𝑏) = 31/1628 = 0.019
𝑝2 = 𝑏/(𝑏 + 𝑑) = 65/4540 = 0.014
𝑹𝑹 =
π’‘πŸ
π’‘πŸ
=
𝟎. πŸŽπŸπŸ—
𝟎. πŸŽπŸπŸ’
= 𝟏. πŸ‘πŸ“πŸ•
ο‚΄Women who give first birth at an older age are 35.7% more
likely to develop breast cancer.
47
Relative Risk (RR) or Risk Ratio
ο‚΄To obtain a CI for the RR
ο‚΄ln(𝑅𝑅) Β± 𝑧1βˆ’
𝛼
2
𝑏
π‘Žπ‘›1
+
𝑑
𝑐𝑛2
ο‚΄Where, 𝑛1 = π‘Ž + 𝑏, 𝑛2 = 𝑐 + 𝑑 and
ln is a natural logarithm.
48
The Odds Ratio
ο‚΄The odds ratio (OR) is the odds in favor of disease for the exposed
group divided by the exposed group divided by the odds in the
favor of disease for the unexposed group.
ο‚΄The odds in favor of disease is 𝑝
(1βˆ’π‘), where, p is probability of a
disease.
49
The Odds Ratio
𝑂𝑑𝑑𝑠 = Pr(𝑒𝑣𝑒𝑛𝑑 π‘œπ‘π‘π‘’π‘Ÿπ‘ )
Pr(𝑒𝑣𝑒𝑛𝑑 π‘‘π‘œπ‘’π‘  π‘›π‘œπ‘‘ π‘œπ‘π‘π‘’π‘Ÿ) = 𝑝
1βˆ’π‘
𝑢𝑹 =
π’‘πŸ
𝟏 βˆ’ π’‘πŸ
π’‘πŸ
𝟏 βˆ’ π’‘πŸ
50
The Odds Ratio
ο‚΄The odds ratio is defined as:
𝑢𝑹 =
π’‘πŸ
𝟏 βˆ’ π’‘πŸ
π’‘πŸ
𝟏 βˆ’ π’‘πŸ
=
π’‘πŸ
π’’πŸ
π’‘πŸ
π’’πŸ
ο‚΄Is estimated by:
𝑂𝑅 =
π’‘πŸ
π’’πŸ
π’‘πŸ
π’’πŸ
=
𝒂
𝒂+𝒃
/ 𝒃
𝒂+𝒃
𝒄
𝒄+𝒅
/ 𝒅
𝒄+𝒅
= 𝒂𝒅
𝒃𝒄
51
The Odds Ratio
ο‚΄Example: in the study of the risk factors for invasive cervical
cancer, the following data were collected (case-control)
52
Smoker Nonsmoker Total
Cancer 108 117 225
No Cancer 163 268 431
Total 271 385 656
The Odds Ratio
ο‚΄The odds ratio is estimated by:
𝑂𝑅 =
108 βˆ— 268
117 βˆ— 163
= 1.52
ο‚΄Women with cancer have an odds of smoking that are 1.52
times the odds of those without cancer.
53
The Odds Ratio
ο‚΄A CI can be constructed for OR as:
ln(𝑂𝑅) Β± 𝑧1βˆ’π›Ό
2
1
π‘Ž
+
1
𝑏
+
1
𝑐
+
1
𝑑
54
The Odds Ratio
ο‚΄Exponentiating the upper and lower confidence limits for the
natural log of the OR
𝑒
π‘™π‘›π‘‚π‘…βˆ’π‘
1
π‘Ž+
1
𝑏+
1
𝑐+
1
𝑑, 𝑒
𝑙𝑛𝑂𝑅+𝑍
1
π‘Ž+
1
𝑏+
1
𝑐+
1
𝑑
55
The Odds Ratio
ο‚΄For Cervical Cancer data
 Therefore, a 95% CI for ln(OR)
ln(1.52) Β± 1.96(0.166)
or
(0.093, 0.744)
56
The Odds Ratio
ο‚΄ A 95% CI for the OR itself is
π’†πŸŽ.πŸŽπŸ—πŸ‘
, π’†πŸŽ.πŸ•πŸ’πŸ’
or
(1.10, 2.13)
ο‚΄ This interval does not contain the value 1
ο‚΄ We conclude that the odds of developing cervical cancer
are significantly higher for smokers than for nonsmokers
57
Quiz (5%)
ο‚΄Consider the total 22,071 people under study;
where 11,037 were assigned to the Aspirin user
group and the rest were assigned to a placebo
group. If 104 people among the Aspirin users have
a Myocardial Infarction case and in total, there are
293 Myocardial Infarction cases, find the Odds
Ratio and Interpret the result.
58
Bias
ο‚΄Describes error arise from the design or execution of
the study.
ο‚΄It’s undesirable
ο‚΄It can’t be adjusted
ο‚΄Useful to consider in any study
ο‚΄Essential to consider in critical appraisal
59
Bias
ο‚΄It’s a systematic error introduced to the study
design.
ο‚΄Two major forms
ο‚΄Selection Bias: refers to any error that arises in the
process of identifying the study subjects.
ο‚΄Information Bias: includes any systematic error in
the measurements on either exposure or outcome
variable.
60
Selection Bias
ο‚΄Selection bias occurs when identification of subjects for
inclusion into a study depends on the interest of the data
collector or investigator.
ο‚΄If selection of cases and controls (eg in case control
study) is based on different criteria, then bias can occur.
ο‚΄There are lots of circumstances selection bias to occur,
but there are two major known forms.
61
Types of Selection Bias
Response Bias:
ο‚΄Those who agree to be in a study may be in some way different
from those who refuse to participate.
Volunteers may be different from those who are listed.
Berksonian Bias:
ο‚΄Bias that is introduced due to differences in criteria/probabilities of
admission to the hospital for those with the disease and those
without the disease.
Admission criteria of the hospital
62
Information Bias
ο‚΄In analytical studies usually one factor is known and another is
measured.
ο‚΄E.g. in case control studies, the β€œoutcome” is known and the
β€œexposure” is measured.
ο‚΄E.g. in cohort studies, the exposure is known and the outcome is
measured.
63
Information Bias
ο‚΄Error in the measurements/information obtained in the study could
be:
οƒ˜ Error due to participants
οƒ˜ Error due to β€œobservers”
οƒ˜ Differential (Non-random)
οƒ˜ Non-differential (Random)
β€’ (i.e. is it influencing equally on the exposure and the outcome?)
64
Types of Information Bias
1. Interviewer Bias: an interviewer’s knowledge of the exposure and
outcome may influence the structure of questions and the manner
of presentation which may influence the response.
2. Recall Bias: those with a particular outcome or exposure may
remember events more clearly or amplify their memories.
3. Observer Bias: Observers may have preconceived expectations of
what they should find in an examination.
4. Lose to follow-up: those who are lost to follow-up or who
withdraw from the study may be different from those who are
followed for the entire study.
65
Types of Information Bias
5. Hawthorne effect: an effect first documented at the Hawthorne
manufacturing plant; people act differently if they know they are
being watched.
6. Surveillance Bias: The group with the known exposure or outcome
may be followed more closely or longer than the comparison
group.
7. Misclassification Bias: Errors are made in classifying either the
disease or exposure status.
66
Confounding Variable
ο‚΄The word came from Latin, β€œconfundere” meaning β€œto
mix up”.
ο‚΄The measured effect of an exposure is distorted because
of the association of the exposure with another factor
(confounder) that influences the outcome.
67
Exposure Outcome
Confounder
Confounding
ο‚΄A problem resulting from the fact that one feature of study
subjects has not been separated from the second feature and has
thus been confounded with it producing a spurious result.
ο‚΄The spuriousness arises from the effect of the effect of the first
feature being mistakenly attributed to the second feature.
ο‚΄Confounding can produce either a type I or a type II error, but we
usually focus on the type I errors.
68
Confounding
ο‚΄At the simplest level, confounding can be thought of as a
confusion of effects.
ο‚΄The apparent effect of the exposure of interest is distorted
because the effect of an extraneous third factor is mixed
with the actual effect.
69
Difference from Bias…
ο‚΄Bias creates an association that is not true; however, confounding
describes an association that is true, but potentially misleading.
ο‚΄Key principle of confounding include that a confounder should be
associated with both the independent and dependent variables
(i.e. with the exposure and the disease)
ο‚΄Association of the confounder with just one of the two variables
is not enough to produce spurious result.
70
Effect of a confounder
ο‚΄Could be large
ο‚΄May produce an over or underestimate of the true effect
ο‚΄May change the apparent direction of the effect
71
Controls for confounding
ο‚΄Controls for confounding may be built into the design or analysis
stages of the study
Design stage
Randomization
Restriction
Matching (on the basis of the potential confounding variables;
especially, age and gender)
Cases and controls can be individually matched for one or more
variables, or they can be group matched.
Matching is more expensive and requires specific analytic
techniques
72
Control Confounding: Analysis Stage
ο‚΄Stratification
ο‚΄Multivariate Analysis: Multiple Linear Regression
73
Matching
ο‚΄ One approach to deal with potential confounders is by matching.
ο‚΄ Matching: is a statistical technique that is used to evaluate the effect of a
treatment by comparing the treated and the non-treated units in a study. It is a
technique that selects subjects so that the distribution of potential
confounders is similar in both groups.
ο‚΄ For example, if we are assessing the effect of opium on total mortality and
sex is a potential confounder, one can match a male opium user to a male
opium non-user and a female opium user to a female opium non-user. This
way users and non-users will be exactly the same for sex, and thus sex could
not confound the association.
ο‚΄ By extension, one can match for more than one variable, such as by age and
sex.
ο‚΄ For example, a 56-year-old male opium user can be matched to a 56-year-
old male non-user.
74

More Related Content

Similar to Principles and Methods of Epidemiologic Study

Measurement of Epidemiology(1).ppt
Measurement of Epidemiology(1).pptMeasurement of Epidemiology(1).ppt
Measurement of Epidemiology(1).pptMuhammadAdnanAkbar5
Β 
MEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxMEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxEmmanuel Ali Adamu
Β 
1st year epidemiology.ppt
1st year epidemiology.ppt1st year epidemiology.ppt
1st year epidemiology.pptSujitKumarBehera16
Β 
Arun epidemio
Arun epidemioArun epidemio
Arun epidemioArun Kumar
Β 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiologymlogaraj
Β 
UNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxUNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxanjalatchi
Β 
Basic epidemiology_Training for Medics
Basic epidemiology_Training for MedicsBasic epidemiology_Training for Medics
Basic epidemiology_Training for MedicsArkar Linn Naing
Β 
Epidemiology, risk,rate,ratio,odd ratio
Epidemiology, risk,rate,ratio,odd ratioEpidemiology, risk,rate,ratio,odd ratio
Epidemiology, risk,rate,ratio,odd ratioSofiulAlam9
Β 
BASIC MEASUREMENTS IN EPIDEMIOLOGY presentation
BASIC MEASUREMENTS IN EPIDEMIOLOGY presentationBASIC MEASUREMENTS IN EPIDEMIOLOGY presentation
BASIC MEASUREMENTS IN EPIDEMIOLOGY presentationPaul523674
Β 
Geography of Health
Geography of HealthGeography of Health
Geography of HealthKeith Phipps
Β 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnmhosn627
Β 
5 mortality and morbidity indicators
5 mortality and morbidity indicators5 mortality and morbidity indicators
5 mortality and morbidity indicatorsAnup Kharde
Β 
Introduction to Epidemiology
Introduction to EpidemiologyIntroduction to Epidemiology
Introduction to EpidemiologyAya Mohamed
Β 
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public HealthKing Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public HealthUWGlobalHealth
Β 
Disease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptxDisease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptxSaeedAbdiali
Β 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PHamitakashyap1
Β 
EPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptx
EPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptxEPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptx
EPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptxJanieRamirez1
Β 
Morbidity and mortality slides
Morbidity and mortality slidesMorbidity and mortality slides
Morbidity and mortality slidesjesus4u
Β 

Similar to Principles and Methods of Epidemiologic Study (20)

Measurement of Epidemiology(1).ppt
Measurement of Epidemiology(1).pptMeasurement of Epidemiology(1).ppt
Measurement of Epidemiology(1).ppt
Β 
MEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptxMEASURES OF MORBIDITY.pptx
MEASURES OF MORBIDITY.pptx
Β 
1st year epidemiology.ppt
1st year epidemiology.ppt1st year epidemiology.ppt
1st year epidemiology.ppt
Β 
Arun epidemio
Arun epidemioArun epidemio
Arun epidemio
Β 
Introduction to epidemiology
Introduction to epidemiologyIntroduction to epidemiology
Introduction to epidemiology
Β 
UNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptxUNIT-IV introduction about ANP course for M.sc I year.pptx
UNIT-IV introduction about ANP course for M.sc I year.pptx
Β 
Basic epidemiology_Training for Medics
Basic epidemiology_Training for MedicsBasic epidemiology_Training for Medics
Basic epidemiology_Training for Medics
Β 
Epidemiology, risk,rate,ratio,odd ratio
Epidemiology, risk,rate,ratio,odd ratioEpidemiology, risk,rate,ratio,odd ratio
Epidemiology, risk,rate,ratio,odd ratio
Β 
BASIC MEASUREMENTS IN EPIDEMIOLOGY presentation
BASIC MEASUREMENTS IN EPIDEMIOLOGY presentationBASIC MEASUREMENTS IN EPIDEMIOLOGY presentation
BASIC MEASUREMENTS IN EPIDEMIOLOGY presentation
Β 
EPIDEMIOLOGY .pptx
EPIDEMIOLOGY  .pptxEPIDEMIOLOGY  .pptx
EPIDEMIOLOGY .pptx
Β 
Geography of Health
Geography of HealthGeography of Health
Geography of Health
Β 
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
18501.pptnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnnn
Β 
5 mortality and morbidity indicators
5 mortality and morbidity indicators5 mortality and morbidity indicators
5 mortality and morbidity indicators
Β 
Introduction to Epidemiology
Introduction to EpidemiologyIntroduction to Epidemiology
Introduction to Epidemiology
Β 
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public HealthKing Holmes, MD, PhD: Present and Future Challenges in Global Public Health
King Holmes, MD, PhD: Present and Future Challenges in Global Public Health
Β 
Disease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptxDisease occurrence measurment lec-4.pptx
Disease occurrence measurment lec-4.pptx
Β 
Basic Concepts of PH
Basic Concepts of PHBasic Concepts of PH
Basic Concepts of PH
Β 
EPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptx
EPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptxEPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptx
EPIDEMIOLOGY- Revised (1) (1) Spring 2023(1).pptx
Β 
Epidemic Diseases
Epidemic DiseasesEpidemic Diseases
Epidemic Diseases
Β 
Morbidity and mortality slides
Morbidity and mortality slidesMorbidity and mortality slides
Morbidity and mortality slides
Β 

Recently uploaded

Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)PraveenaKalaiselvan1
Β 
Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.
Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.
Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.aasikanpl
Β 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoSΓ©rgio Sacani
Β 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptMAESTRELLAMesa2
Β 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...SΓ©rgio Sacani
Β 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Lokesh Kothari
Β 
Stunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCR
Stunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCRStunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCR
Stunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCRDelhi Call girls
Β 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxAleenaTreesaSaji
Β 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptxkhadijarafiq2012
Β 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptxanandsmhk
Β 
Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...anilsa9823
Β 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...RohitNehra6
Β 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Nistarini College, Purulia (W.B) India
Β 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsSΓ©rgio Sacani
Β 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfSumit Kumar yadav
Β 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PPRINCE C P
Β 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTSΓ©rgio Sacani
Β 

Recently uploaded (20)

Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)Recombinant DNA technology (Immunological screening)
Recombinant DNA technology (Immunological screening)
Β 
Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.
Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.
Call Girls in Munirka Delhi πŸ’―Call Us πŸ”9953322196πŸ” πŸ’―Escort.
Β 
Isotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on IoIsotopic evidence of long-lived volcanism on Io
Isotopic evidence of long-lived volcanism on Io
Β 
G9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.pptG9 Science Q4- Week 1-2 Projectile Motion.ppt
G9 Science Q4- Week 1-2 Projectile Motion.ppt
Β 
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
PossibleEoarcheanRecordsoftheGeomagneticFieldPreservedintheIsuaSupracrustalBe...
Β 
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Labelling Requirements and Label Claims for Dietary Supplements and Recommend...
Β 
Stunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCR
Stunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCRStunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCR
Stunning βž₯8448380779β–» Call Girls In Panchshil Enclave Delhi NCR
Β 
GFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptxGFP in rDNA Technology (Biotechnology).pptx
GFP in rDNA Technology (Biotechnology).pptx
Β 
Types of different blotting techniques.pptx
Types of different blotting techniques.pptxTypes of different blotting techniques.pptx
Types of different blotting techniques.pptx
Β 
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptxUnlocking  the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Unlocking the Potential: Deep dive into ocean of Ceramic Magnets.pptx
Β 
Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Lucknow πŸ’‹ Russian Call Girls Lucknow Finest Escorts Service 8923113531 Availa...
Β 
The Philosophy of Science
The Philosophy of ScienceThe Philosophy of Science
The Philosophy of Science
Β 
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Biopesticide (2).pptx  .This slides helps to know the different types of biop...Biopesticide (2).pptx  .This slides helps to know the different types of biop...
Biopesticide (2).pptx .This slides helps to know the different types of biop...
Β 
CELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdfCELL -Structural and Functional unit of life.pdf
CELL -Structural and Functional unit of life.pdf
Β 
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...Bentham & Hooker's Classification. along with the merits and demerits of the ...
Bentham & Hooker's Classification. along with the merits and demerits of the ...
Β 
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroidsHubble Asteroid Hunter III. Physical properties of newly found asteroids
Hubble Asteroid Hunter III. Physical properties of newly found asteroids
Β 
Engler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomyEngler and Prantl system of classification in plant taxonomy
Engler and Prantl system of classification in plant taxonomy
Β 
Botany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdfBotany 4th semester file By Sumit Kumar yadav.pdf
Botany 4th semester file By Sumit Kumar yadav.pdf
Β 
Artificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C PArtificial Intelligence In Microbiology by Dr. Prince C P
Artificial Intelligence In Microbiology by Dr. Prince C P
Β 
Disentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOSTDisentangling the origin of chemical differences using GHOST
Disentangling the origin of chemical differences using GHOST
Β 

Principles and Methods of Epidemiologic Study

  • 1. College of Computing and Informatics Department of Statistics Biostatistics and Epidemiology Chapter 1: Principles and Methods of Epidemiology By: Dugo G. (MSc.) Email: dugojgadisa@gmail.com or Dugo.Gadisa@haramaya.edu.et 1
  • 2. Introduction to Epidemiology and Biostatistics What is the difference between the two? ο‚΄Biostatistics is the application of statistical methods in biology, medicine, public health, and other fields of study. ο‚΄Epidemiology is the study of patterns of health and illness and associated factors at the population level (disease distribution, prevalence, mechanisms of prevention, etc.) 2
  • 3. Introduction to Epidemiology Definitions of Epidemiology ο‚΄It is a study of the distribution of a disease or a physiological condition in human populations and the factors that influence this distribution. ο‚΄It is a study of the distribution and determinants of health- related states and events in populations and the application of this study to control health problems. 3
  • 4. What is Epidemiology? ο‚΄In general, Epidemiology can be defined as the study of determinants, distribution, and frequency of disease. 4
  • 5. Uses of Epidemiology a. Community diagnosis; i.e., what are the major health problems occurring in a community b. Establishing the history of a disease in a population; e.g., identifying the periodicity of an infectious disease c. Describing the natural history of disease in the individual; e.g., natural history of Cancer in the individual (from its pathological onset (inception) to resolution (recovery or death), clinical stages) 5
  • 6. Uses of Epidemiology d. Describing the clinical picture of the disease; i.e., who gets the disease, who dies from the disease, and what the outcome of the disease is e. Estimating risk; e.g., what factors increase the risk of heart disease, automobile accidents, and violence f. Identifying syndromes and precursors; e.g., the relationship of high blood pressure to stroke, kidney disease, and heart disease ο‚΄Syndromes: a group of signs and symptoms that consistently occur together and characterize a particular abnormality or condition. ο‚΄Precursors: a substance, cell, or cellular component from which another substance, cell, or cellular component is formed 6
  • 7. Uses of Epidemiology g. Evaluating prevention/intervention programs; e.g., vaccine and clinical trials h. Investigating epidemics/diseases of unknown etiology. ο‚΄Etiology encompasses understanding why a particular condition or disease occurs. 7
  • 8. Some Epidemiologic Concepts Catchment area: ο‚΄The geographical area from which the people attending a particular health facility come. Catchment population : ο‚΄People attending particular health facilities ο‚΄Population at risk: is vital to know all people at risk of developing a disease or having a health problem, as well as those who are currently suffering from it. 8
  • 9. Some Epidemiologic Concepts ο‚΄Incidence: the number of new cases, or events occurring over a defined period of time, commonly one year. ο‚΄Prevalence: the total number of existing cases, episodes or events occurring at one point in time, commonly on a particular day. 9
  • 11. Some Epidemiologic Concepts ο‚΄Case: A person who is identified as having a particular characteristic such as a disease, behavior, or condition. Cases may be divided into possible, probable, and definite, depending on how well specific criteria are satisfied ο‚΄Controls: refer to a specific group of individuals who serve as a comparison for the group of people with a particular disease (known as cases). 11
  • 12. Some Epidemiologic Concepts ο‚΄Epidemic: the occurrence in a community or region of cases of an illness or other similar event clearly in excess of what is normally expected. The characteristics of the illness, the area and the season all have to be taken into account. ο‚΄Epidemic incidence curve: a graph that plots cases of the disease by the time of onset of the illness. An essential part of the analysis is this graph can indicate the nature of the outbreak and the probable source. 12
  • 13. Mortality Rate ο‚΄Crude Death Rate (CDR) = π‘‡π‘œπ‘‘π‘Žπ‘™ π‘›π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘œπ‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ πΈπ‘ π‘‘π‘–π‘šπ‘Žπ‘‘π‘’π‘‘ π‘šπ‘–π‘‘ π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› βˆ— 1000 ο‚΄The crude death rate was 5.995 per 1,000 in Ethiopia in 2023. ο‚΄The crude death rate in Addis Ababa was approximately 6.29 per 1000 (data of 2020). 13
  • 14. Age-specific Mortality Rate ο‚΄Age-specific mortality rate = π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑖𝑛 π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘Žπ‘”π‘’ π‘”π‘Ÿπ‘œπ‘’π‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ πΈπ‘ π‘‘π‘–π‘šπ‘Žπ‘‘π‘’π‘‘ π‘šπ‘–π‘‘βˆ’π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘œπ‘“ 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘Žπ‘”π‘’ π‘”π‘Ÿπ‘œπ‘’π‘ βˆ— 1000 ο‚΄One example of age specific mortality rate is Infant Mortality Rate. 14
  • 15. Sex-Specific Mortality Rate ο‚΄Sex-specific mortality rate = π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  𝑖𝑛 π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 𝑠𝑒π‘₯ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ πΈπ‘ π‘‘π‘–π‘šπ‘Žπ‘‘π‘’π‘‘ π‘šπ‘–π‘‘βˆ’π‘–π‘›π‘‘π‘’π‘Ÿπ‘£π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘œπ‘“ π‘ π‘Žπ‘šπ‘’ 𝑠𝑒π‘₯ βˆ— 1000 Example: The average total population of β€œTown A” in 2019 was 6000 (3500 female & 2500 male). In the same year, 300 people died (100 female and 200 male). Calculate the Crude death rate and mortality rate for females. 15
  • 16. Case Fatality Rate ο‚΄Case Fatality Rate (CFR) = π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘“π‘Ÿπ‘œπ‘š π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘‘π‘–π‘ π‘’π‘Žπ‘ π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π‘π‘œ π‘œπ‘“ π‘π‘Žπ‘ π‘’π‘  π‘œπ‘“ π‘‘β„Žπ‘Žπ‘‘ π‘‘π‘–π‘ π‘’π‘Žπ‘ π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’ βˆ— 100 ο‚΄Example: In 1996, there were 1000 tuberculosis patients in one region. Out of the 1000 patients, 100 died in the same year. Calculate the case fatality rate of tuberculosis. 16
  • 17. Neonatal Mortality Rate ο‚΄Neonatal Mortality Rate = π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘’π‘›π‘‘π‘’π‘Ÿ 28 π‘‘π‘Žπ‘¦π‘  π‘œπ‘“ π‘Žπ‘”π‘’ π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π‘π‘œ π‘œπ‘“ 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’ βˆ— 1000 ο‚΄Example: In 2010, there were a total of 5000 live births in β€œZone B”. Two hundred of them died before 28 days after birth. Calculate the Neonatal Mortality Rate (NMR). ο‚΄Answer: NMR = 200 500 βˆ— 1000 = 40 π‘π‘’π‘Ÿ 1000 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  ο‚΄That means out of 1000 live births in 2010, 40 of them died before 28 days after birth. 17
  • 18. Infant Mortality Rate (IMR) ο‚΄Infant Mortality Rate (IMR) = π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘œπ‘“ π‘’π‘›π‘‘π‘’π‘Ÿ 1 π‘¦π‘’π‘Žπ‘Ÿ π‘œπ‘“ π‘Žπ‘”π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π‘π‘œ π‘œπ‘“ 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  π‘Ÿπ‘’π‘π‘œπ‘Ÿπ‘‘π‘’π‘‘ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’ βˆ— 1000 18
  • 19. Under-Five Mortality Rate ο‚΄Under-five mortality rate = π‘π‘œ π‘œπ‘“ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘œπ‘“ 0βˆ’4 π‘¦π‘’π‘Žπ‘Ÿπ‘  π‘œπ‘“ π‘Žπ‘”π‘’ π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π΄π‘£π‘’π‘Ÿπ‘Žπ‘”π‘’ π‘šπ‘–π‘‘βˆ’π‘¦π‘’π‘Žπ‘Ÿ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘œπ‘“ π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘Žπ‘”π‘’ π‘Žπ‘‘ π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’ βˆ— 1000 ο‚΄ NB: The numerator says 0-4 years. 0-4 years in this formula means children from birth to less than five years of age i.e. the upper age limit is not 4. ο‚΄ Example: In 1996, the total number of children under 5 years of age was 10,000 in β€œZone C”. In the same year, 200 children under five years of age died. Calculate the under-five mortality rate (U5MR). ο‚΄ U5MR = 200 10000 βˆ— 1000 = 20 π‘π‘’π‘Ÿ 1000 π‘’π‘›π‘‘π‘’π‘Ÿ 𝑓𝑖𝑣𝑒 π‘β„Žπ‘–π‘™π‘‘π‘Ÿπ‘’π‘› 19
  • 20. Maternal Mortality Rate ο‚΄ Maternal Mortality Rate = π‘π‘œ π‘œπ‘“ π‘π‘Ÿπ‘’π‘”π‘›π‘Žπ‘›π‘π‘¦ π‘Žπ‘ π‘ π‘œπ‘π‘–π‘Žπ‘‘π‘’π‘‘ π‘‘π‘’π‘Žπ‘‘β„Žπ‘  π‘œπ‘“ π‘šπ‘œπ‘‘β„Žπ‘’π‘Ÿπ‘  𝑖𝑛 π‘Ž 𝑔𝑖𝑣𝑒𝑛 π‘‘π‘–π‘šπ‘’ π‘π‘œ π‘œπ‘“ 𝑙𝑖𝑣𝑒 π‘π‘–π‘Ÿπ‘‘β„Žπ‘  𝑖𝑛 π‘‘β„Žπ‘’ π‘ π‘Žπ‘šπ‘’ π‘‘π‘–π‘šπ‘’ βˆ— 1000 ο‚΄ Maternal Mortality Rate reflects the standards of all aspects of maternal care (antenatal, delivery, and postnatal). ο‚΄ The Maternal Mortality Rate in Ethiopia is estimated to be between 267 to 412 per 100,000 live births in 2020. ο‚΄ That means in 100,000 live births, on average around 340 mothers die each year due to pregnancy-related causes. 20
  • 21. Scope of Epidemiology ο‚΄Its scope at the beginning was limited to understanding epidemics ο‚΄Now it is the basis of advancing our understanding of all kinds of diseases included: ο‚΄Nutritional deficiencies ο‚΄Infectious and non-infectious diseases ο‚΄ Injuries and accidents ο‚΄Mental disorders ο‚΄Maternal and Child Health ο‚΄Cancer ο‚΄Occupational Health ο‚΄Environmental Health ο‚΄Health behaviors 21
  • 22. Measuring Disease Frequency It Has several Components ο‚΄Classifying and categorizing disease ο‚΄Defining the period of time of risk of disease ο‚΄Deciding what constitutes a case of disease in a study ο‚΄Obtaining permission to study people ο‚΄Making measurements of disease frequency ο‚΄Finding a source for ascertaining the cases ο‚΄Relating cases to population and time at risk ο‚΄Defining the population at risk of disease 22
  • 23. The Basic Triad of Descriptive Epidemiology ο‚΄The three essential characteristics of disease we look for in descriptive epidemiology: TIME PLACE PERSON 23
  • 24. Time There are three major kinds of changes in disease occurrence over time. 1. SECULAR TRENDS (slowly change): This refers to gradual changes over long period of time, such as years or decades. E.g. AIDS, cancer. 2. PERIODIC OR CYCLIC CHANGES. This refers to recurrent alterations in the frequency of diseases. ο‚΄Cycles may be annual or have some other periodicity. E.g. measles, malaria, meningitis. 3. SPORADIC: irregular and unpredictable intervals. ο‚΄E.g. influenza, Allergies 24
  • 25. Time (Cont’d…) ο‚΄Secular trend can be due to one or more of the following factors. 1. Change in diagnostic technique 2. Change in accuracy of enumerating population at risk. 3. Change in age distribution of the people. 4. Change of survival from disease. 5. Change in actual incidence of the disease. 25
  • 26. Time (Cont’d…) ο‚΄Changing or Stable ο‚΄Seasonal Variation ο‚΄Clustered (Epidemic) or evenly distributed (Endemic) ο‚΄Point source or Propagated 26
  • 27. Place ο‚΄The frequency of disease is different in different places. ο‚΄Natural barriers: environmental or climatic conditions, such as temperature, humidity, rainfall, altitude, mineral content of soil, or water supply ο‚΄Political boundaries: Intended for planning and allocation of resources ο‚΄Urban-rural differences in disease occurrence: in terms of migration, style of living and differential environmental exposures also helpful 27
  • 28. Place (Cont’d…) ο‚΄Geographically restricted or widespread (Pandemic) ο‚΄Relation to food or water supply ο‚΄Multiple clusters or one 28
  • 30. Person (Who) ο‚΄Young vs Old ο‚΄Female vs male ο‚΄Rich vs Poor ο‚΄Illiterate Vs educate Place (Where) ο‚΄Lowland vs Highland ο‚΄Urban vs Rural Time (When) ο‚΄Day/night variation ο‚΄Seasonal variation ο‚΄Long term 30
  • 31. Disease Occurrence Dynamics of Disease Transmission ο‚΄Interaction of agents and environmental factors with human hosts ο‚΄Distribution of severity of diseases ο‚΄Modes of disease transmission ο‚΄Level of disease in community when transmission stops 31
  • 32. The Basic Triad of Analytic Epidemiology ο‚΄The three phenomena assessed in Analytic Epidemiology are: Host Agent Environment 32
  • 33. The Basic Triad of Analytic Epidemiology ο‚΄Host: In epidemiology, the host is usually a human who gets sick but can also be an animal that acts as a carrier of disease but may or may not present illness. ο‚΄Agent: Epidemiologic triangle agents include Bacteria, Viruses, Fungi, Protozoa, et cetera. ο‚΄Environment: The environment represents the favorable conditions for an agent to cause a health event. Environmental factors include physical features like geology or climate, biological factors like the presence of disease-transmitting insects, and socioeconomic factors like crowding, sanitation, and access to health services. 33
  • 35. When Calculating DF(disease frequency) ο‚΄The numerator (number of cases/episodes) ο‚΄The denominator (total population at risk) ο‚΄Factor (e.g. 100, 1000, 10000) ο‚΄Time period (dates, weeks, months, or years) ο‚΄We use the following to determine DF. ο‚΄Use rates: incidence rates ο‚΄Prevalence rates 35
  • 36. Incidence and Prevalence rates ο‚΄Decide what are you counting. ο‚΄Episodes/cases, people, attendance or what? ο‚΄What is the service count when filling monthly statistics eg. diarrhea or malaria ο‚΄people get repeated attacks in one month and attend your service ο‚΄This is one person sick but has suffered several times separate episodes in one year and attended your service several times 36
  • 37. Incidence and Prevalence rates ο‚΄Incidence: Count episodes/cases ο‚΄Prevalence: chronic conditions/diseases which count the total number of sick people. ο‚΄To study the use of health services, informations on new attendance and repeat attendance are required. 37
  • 38. When Calculating: ο‚΄Incidence rate: 𝐼𝑅 = π‘π‘œ π‘œπ‘“ 𝑛𝑒𝑀 π‘π‘Žπ‘ π‘’π‘  π‘œπ‘“ π‘Ž π‘‘π‘–π‘ π‘’π‘Žπ‘ π‘’ π‘œπ‘£π‘’π‘Ÿ π‘Ž π‘π‘’π‘Ÿπ‘–π‘œπ‘‘ π‘œπ‘“ π‘‘π‘–π‘šπ‘’ π‘‡π‘œπ‘‘π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› π‘‘π‘’π‘Ÿπ‘–π‘›π‘” π‘‘β„Žπ‘’ 𝑔𝑖𝑣𝑒𝑛 π‘π‘’π‘Ÿπ‘–π‘œπ‘‘ π‘œπ‘“ π‘‘π‘–π‘šπ‘’ βˆ— 𝐾 ο‚΄Prevalence rate: 𝑃𝑅 = 𝐴𝑙𝑙 π‘π‘’π‘Ÿπ‘ π‘œπ‘›π‘  π‘€π‘–π‘‘β„Ž π‘Ž 𝑠𝑝𝑒𝑐𝑖𝑓𝑖𝑐 π‘π‘œπ‘›π‘‘π‘–π‘‘π‘–π‘œπ‘›π‘  π‘Žπ‘‘ π‘œπ‘›π‘’ π‘π‘œπ‘–π‘›π‘‘ 𝑖𝑛 π‘‘π‘–π‘šπ‘’ π‘‡π‘œπ‘‘π‘Žπ‘™ π‘ƒπ‘œπ‘π‘’π‘™π‘Žπ‘‘π‘–π‘œπ‘› βˆ— 𝐾 38
  • 39. Example 1: In September 1995 there were 200 new cases of relapsing fever in β€œKebele X”. The average total population of β€œKebele X” was 4000. Calculate the incidence rate of relapsing fever in β€œKebele X” in September 1995. Answer: 50 new cases per 1000 Example 2: 5,600,000 people in South Africa were estimated to be infected with HIV in 2009 with a total population of 53 million. What is the prevalence of HIV in the South? Answer: 39
  • 40. Comparing Incidence and Prevalence Incidence ο‚΄New cases or events over a period of time ο‚΄Useful to study factors causing risks Prevalence ο‚΄All cases at a point/interval of time ο‚΄Useful for measuring the size of the problem and planning 40
  • 41. Relationship of Incidence to Prevalence ο‚΄Prevalence depends on both on incidence rate and duration of disease ο‚΄Because prevalence is affected by factors such as migration and duration, incidence is preferred for studying etiology. ο‚΄Prevalence = Incidence X Duration 41
  • 42. Relationship between Incidence, Prevalence and Disease Duration 42 Incidence Prevalence Death Lost to follow up Cure
  • 43. Attack Rate ο‚΄Example: Consider the outbreak of cholera in country Y in March 2016. 490 population with cholera and the population at risk were 18,600. What is the AR? ο‚΄Answer: 𝐴𝑅 = 490 18,600 βˆ— 100% = 2.6% 43
  • 44. Relative Risk (RR) or Risk Ratio ο‚΄Defined as the ratio of the incidence of disease in the exposed divided by the corresponding non-exposed group. 44 Exposure Disease Total Yes No Yes a b a+b No c d c+d Total a+c b+d N
  • 45. Relative Risk (RR) or Risk Ratio ο‚΄Where, 𝑝1 = π‘Ž/(π‘Ž + 𝑏) and 𝑝2 = 𝑐/(𝑐 + 𝑑) ο‚΄A point estimate of the risk ratio is given by: οƒ˜ 𝑅𝑅 = 𝑝1 𝑝2 45
  • 46. Relative Risk (RR) or Risk Ratio Example 46 1st give Birth Breast Cancer Total Yes No β‰₯25 years 31 1597 1628 <25 years 65 4475 4540 96 6072 6168
  • 47. Relative Risk (RR) or Risk Ratio 𝑝1 = π‘Ž/(π‘Ž + 𝑏) = 31/1628 = 0.019 𝑝2 = 𝑏/(𝑏 + 𝑑) = 65/4540 = 0.014 𝑹𝑹 = π’‘πŸ π’‘πŸ = 𝟎. πŸŽπŸπŸ— 𝟎. πŸŽπŸπŸ’ = 𝟏. πŸ‘πŸ“πŸ• ο‚΄Women who give first birth at an older age are 35.7% more likely to develop breast cancer. 47
  • 48. Relative Risk (RR) or Risk Ratio ο‚΄To obtain a CI for the RR ο‚΄ln(𝑅𝑅) Β± 𝑧1βˆ’ 𝛼 2 𝑏 π‘Žπ‘›1 + 𝑑 𝑐𝑛2 ο‚΄Where, 𝑛1 = π‘Ž + 𝑏, 𝑛2 = 𝑐 + 𝑑 and ln is a natural logarithm. 48
  • 49. The Odds Ratio ο‚΄The odds ratio (OR) is the odds in favor of disease for the exposed group divided by the exposed group divided by the odds in the favor of disease for the unexposed group. ο‚΄The odds in favor of disease is 𝑝 (1βˆ’π‘), where, p is probability of a disease. 49
  • 50. The Odds Ratio 𝑂𝑑𝑑𝑠 = Pr(𝑒𝑣𝑒𝑛𝑑 π‘œπ‘π‘π‘’π‘Ÿπ‘ ) Pr(𝑒𝑣𝑒𝑛𝑑 π‘‘π‘œπ‘’π‘  π‘›π‘œπ‘‘ π‘œπ‘π‘π‘’π‘Ÿ) = 𝑝 1βˆ’π‘ 𝑢𝑹 = π’‘πŸ 𝟏 βˆ’ π’‘πŸ π’‘πŸ 𝟏 βˆ’ π’‘πŸ 50
  • 51. The Odds Ratio ο‚΄The odds ratio is defined as: 𝑢𝑹 = π’‘πŸ 𝟏 βˆ’ π’‘πŸ π’‘πŸ 𝟏 βˆ’ π’‘πŸ = π’‘πŸ π’’πŸ π’‘πŸ π’’πŸ ο‚΄Is estimated by: 𝑂𝑅 = π’‘πŸ π’’πŸ π’‘πŸ π’’πŸ = 𝒂 𝒂+𝒃 / 𝒃 𝒂+𝒃 𝒄 𝒄+𝒅 / 𝒅 𝒄+𝒅 = 𝒂𝒅 𝒃𝒄 51
  • 52. The Odds Ratio ο‚΄Example: in the study of the risk factors for invasive cervical cancer, the following data were collected (case-control) 52 Smoker Nonsmoker Total Cancer 108 117 225 No Cancer 163 268 431 Total 271 385 656
  • 53. The Odds Ratio ο‚΄The odds ratio is estimated by: 𝑂𝑅 = 108 βˆ— 268 117 βˆ— 163 = 1.52 ο‚΄Women with cancer have an odds of smoking that are 1.52 times the odds of those without cancer. 53
  • 54. The Odds Ratio ο‚΄A CI can be constructed for OR as: ln(𝑂𝑅) Β± 𝑧1βˆ’π›Ό 2 1 π‘Ž + 1 𝑏 + 1 𝑐 + 1 𝑑 54
  • 55. The Odds Ratio ο‚΄Exponentiating the upper and lower confidence limits for the natural log of the OR 𝑒 π‘™π‘›π‘‚π‘…βˆ’π‘ 1 π‘Ž+ 1 𝑏+ 1 𝑐+ 1 𝑑, 𝑒 𝑙𝑛𝑂𝑅+𝑍 1 π‘Ž+ 1 𝑏+ 1 𝑐+ 1 𝑑 55
  • 56. The Odds Ratio ο‚΄For Cervical Cancer data  Therefore, a 95% CI for ln(OR) ln(1.52) Β± 1.96(0.166) or (0.093, 0.744) 56
  • 57. The Odds Ratio ο‚΄ A 95% CI for the OR itself is π’†πŸŽ.πŸŽπŸ—πŸ‘ , π’†πŸŽ.πŸ•πŸ’πŸ’ or (1.10, 2.13) ο‚΄ This interval does not contain the value 1 ο‚΄ We conclude that the odds of developing cervical cancer are significantly higher for smokers than for nonsmokers 57
  • 58. Quiz (5%) ο‚΄Consider the total 22,071 people under study; where 11,037 were assigned to the Aspirin user group and the rest were assigned to a placebo group. If 104 people among the Aspirin users have a Myocardial Infarction case and in total, there are 293 Myocardial Infarction cases, find the Odds Ratio and Interpret the result. 58
  • 59. Bias ο‚΄Describes error arise from the design or execution of the study. ο‚΄It’s undesirable ο‚΄It can’t be adjusted ο‚΄Useful to consider in any study ο‚΄Essential to consider in critical appraisal 59
  • 60. Bias ο‚΄It’s a systematic error introduced to the study design. ο‚΄Two major forms ο‚΄Selection Bias: refers to any error that arises in the process of identifying the study subjects. ο‚΄Information Bias: includes any systematic error in the measurements on either exposure or outcome variable. 60
  • 61. Selection Bias ο‚΄Selection bias occurs when identification of subjects for inclusion into a study depends on the interest of the data collector or investigator. ο‚΄If selection of cases and controls (eg in case control study) is based on different criteria, then bias can occur. ο‚΄There are lots of circumstances selection bias to occur, but there are two major known forms. 61
  • 62. Types of Selection Bias Response Bias: ο‚΄Those who agree to be in a study may be in some way different from those who refuse to participate. Volunteers may be different from those who are listed. Berksonian Bias: ο‚΄Bias that is introduced due to differences in criteria/probabilities of admission to the hospital for those with the disease and those without the disease. Admission criteria of the hospital 62
  • 63. Information Bias ο‚΄In analytical studies usually one factor is known and another is measured. ο‚΄E.g. in case control studies, the β€œoutcome” is known and the β€œexposure” is measured. ο‚΄E.g. in cohort studies, the exposure is known and the outcome is measured. 63
  • 64. Information Bias ο‚΄Error in the measurements/information obtained in the study could be: οƒ˜ Error due to participants οƒ˜ Error due to β€œobservers” οƒ˜ Differential (Non-random) οƒ˜ Non-differential (Random) β€’ (i.e. is it influencing equally on the exposure and the outcome?) 64
  • 65. Types of Information Bias 1. Interviewer Bias: an interviewer’s knowledge of the exposure and outcome may influence the structure of questions and the manner of presentation which may influence the response. 2. Recall Bias: those with a particular outcome or exposure may remember events more clearly or amplify their memories. 3. Observer Bias: Observers may have preconceived expectations of what they should find in an examination. 4. Lose to follow-up: those who are lost to follow-up or who withdraw from the study may be different from those who are followed for the entire study. 65
  • 66. Types of Information Bias 5. Hawthorne effect: an effect first documented at the Hawthorne manufacturing plant; people act differently if they know they are being watched. 6. Surveillance Bias: The group with the known exposure or outcome may be followed more closely or longer than the comparison group. 7. Misclassification Bias: Errors are made in classifying either the disease or exposure status. 66
  • 67. Confounding Variable ο‚΄The word came from Latin, β€œconfundere” meaning β€œto mix up”. ο‚΄The measured effect of an exposure is distorted because of the association of the exposure with another factor (confounder) that influences the outcome. 67 Exposure Outcome Confounder
  • 68. Confounding ο‚΄A problem resulting from the fact that one feature of study subjects has not been separated from the second feature and has thus been confounded with it producing a spurious result. ο‚΄The spuriousness arises from the effect of the effect of the first feature being mistakenly attributed to the second feature. ο‚΄Confounding can produce either a type I or a type II error, but we usually focus on the type I errors. 68
  • 69. Confounding ο‚΄At the simplest level, confounding can be thought of as a confusion of effects. ο‚΄The apparent effect of the exposure of interest is distorted because the effect of an extraneous third factor is mixed with the actual effect. 69
  • 70. Difference from Bias… ο‚΄Bias creates an association that is not true; however, confounding describes an association that is true, but potentially misleading. ο‚΄Key principle of confounding include that a confounder should be associated with both the independent and dependent variables (i.e. with the exposure and the disease) ο‚΄Association of the confounder with just one of the two variables is not enough to produce spurious result. 70
  • 71. Effect of a confounder ο‚΄Could be large ο‚΄May produce an over or underestimate of the true effect ο‚΄May change the apparent direction of the effect 71
  • 72. Controls for confounding ο‚΄Controls for confounding may be built into the design or analysis stages of the study Design stage Randomization Restriction Matching (on the basis of the potential confounding variables; especially, age and gender) Cases and controls can be individually matched for one or more variables, or they can be group matched. Matching is more expensive and requires specific analytic techniques 72
  • 73. Control Confounding: Analysis Stage ο‚΄Stratification ο‚΄Multivariate Analysis: Multiple Linear Regression 73
  • 74. Matching ο‚΄ One approach to deal with potential confounders is by matching. ο‚΄ Matching: is a statistical technique that is used to evaluate the effect of a treatment by comparing the treated and the non-treated units in a study. It is a technique that selects subjects so that the distribution of potential confounders is similar in both groups. ο‚΄ For example, if we are assessing the effect of opium on total mortality and sex is a potential confounder, one can match a male opium user to a male opium non-user and a female opium user to a female opium non-user. This way users and non-users will be exactly the same for sex, and thus sex could not confound the association. ο‚΄ By extension, one can match for more than one variable, such as by age and sex. ο‚΄ For example, a 56-year-old male opium user can be matched to a 56-year- old male non-user. 74